MedTrace Logo

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

NCT04427930 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2023-07-10

No results posted yet for this study

Summary

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Conditions

Interventions

BIOLOGICAL

JOINTSTEM

Autologous Adipose Tissue derived MSCs

Sponsors & Collaborators

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • KANGIL KIM · KyungHee University Gangdong Hospital

  • WOOSUK LEE · Gangnam Severance Hospital

  • KICHEOR BAE · Keimyung University Dongsan Medical Center

  • YONG IN · The Catholic University of Korea

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2026-12-23
Completion
2027-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427930 on ClinicalTrials.gov